Skip to search formSkip to main contentSkip to account menu

PB 100

Known as: PB-100, PB100 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

flavopereirine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Radio free everywhere [Resources]
Last year, we inaugurated IEEE Spectrum’s online Chip Hall of Fame, highlighting 27 integrated circuits that helped shape the… 
2012
2012
PB-100 文章読解に対する読みの目標とメタ認知能力の影響(2) : 読みの目標を設定しない場合との比較(教授・学習,ポスター発表)
2007
2007
PB100 障害者に対する大学生と専門学校生の意識(1)
2004
2004
PB100 小学生の学力差拡大傾向抑制をめざした単元間の関連付け授業の効果(4)(ポスター発表B,研究発表)
2001
2001
PB100 進路の選択と決定に関する研究 (10) : ジェンダーの視点から
2000
2000
PB100 「学習障害」を主訴とする青年の障害理解について (その2) : 障害理解を進めるための評価をめぐる検討
1996
1996
The selective anticancer agents PB-100 and BG-8 are active against human melanoma cells, but do not affect non malignant fibroblasts.
When past the stage amenable to surgery, melanoma and its metastases are, as a rule, treated with chemotherapy, which is largely… 
1995
1995
The anticancer agent pb-100 concentrates in the nucleus and nucleoli of human glioblastoma cells but does not enter normal astrocytes.
Selectivity of the anticancer agent PB-100 for malignant cells, already demonstrated using cell growth and viability evaluation… 
1994
1994
The selective anticancer agent pb-100 inhibits interleukin-6 induced enhancement of glioblastoma cell-proliferation in-vitro.
The multifunctional cytokine interleukin-6 behaves as a growth factor for various malignancies. It is produced in significant… 
1993
1993
PB-100: a potent and selective inhibitor of human BCNU resistant glioblastoma cell multiplication.
Major drawbacks to present-day cancer chemotherapy are its intrinsic lack of selectivity for tumour cells, resulting in severe…